International Commercialization

 

Your product development is complete. Regulatory certification is pending.  What is your strategy and plan for commercializing your product internationally to its end user? Is your product positioned for maximum market revenues? Do you have sufficient market information for  real-time business decisions? Have you identified and contacted the key accounts in each target territory?  What are your next steps along the road towards a win-win deal outcome?

Commercialization services from BioTechCatalyst will expertly and quickly assist you in preparing a tailor-made Commercialization Action Plan. The very process of plan preparation and formulation necessitates an assessment and review of the business environment in which you are operating. In particular, your key success factors and competitive landscape. Clarifying these factors enables the formulation of your international marketing strategy for commercialization.  With a plan and strategy in place effective real-time decision making and focused activities can quickly move forward.

BioTechCatalyst factors in the following information while formulating the plan (which should be updated at least annually):

  • The Market (growing/declining, major and minor players and their market share, SWOT analysis, market trends and regulatory requirements)
  • Project Risks
  • Barriers to competition; IP protection
  • Your technology's/product's competitive or unique advantage
  • Key Customers and the End user
  • Key Decision makers and Decision criteria
  • Market Entry Strategy
  • Distribution channels and associated margins; Distributor options;
  • Pricing strategy (high/low); Realistic selling price (versus operational and marketing costs);
  • Financial sponsors and resources;
  • Product Line extensions;
  • Company and project management resources;
  • Exit strategy options for your investors.

Depending on your needs BioTechCatalyst's Commercialization services are also operational. Upon completion of the Commercialization Action Plan BioTechCatalyst can work "hands on" with you as your Commercialization Manager or interim CEO, for the short or long term, in expertly and efficiently implementing the Commercialization plan.

 

Back to Services  |  Back to International Clients

 - Albert Einstein (1879 - 1955)
Favorite quote: "The important thing is not to stop questioning."
 |  Home  |  Advantages  |  About BioTechCatalyst  |  Services  |  International Clients  |  Services - Detailed Information  |  Links  |  Contact Us  |  Site Map  |